Global Gene Therapy for Ovarian Cancer Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intravenous
1.2.3 Intratumoral
1.2.4 Intraperitoneal
1.3 Market by Application
1.3.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Ovarian Cancer (Unspecified)
1.3.3 Recurrent Ovarian Epithelial Cancer
1.3.4 Platinum-Resistant Ovarian Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2018-2029)
2.2 Global Gene Therapy for Ovarian Cancer Growth Trends by Region
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy for Ovarian Cancer Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy for Ovarian Cancer Market Dynamics
2.3.1 Gene Therapy for Ovarian Cancer Industry Trends
2.3.2 Gene Therapy for Ovarian Cancer Market Drivers
2.3.3 Gene Therapy for Ovarian Cancer Market Challenges
2.3.4 Gene Therapy for Ovarian Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy for Ovarian Cancer by Players
3.1.1 Global Gene Therapy for Ovarian Cancer Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy for Ovarian Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio
3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2022
3.5 Global Key Players of Gene Therapy for Ovarian Cancer Head office and Area Served
3.6 Global Key Players of Gene Therapy for Ovarian Cancer, Product and Application
3.7 Global Key Players of Gene Therapy for Ovarian Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Ovarian Cancer Breakdown Data by Type
4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2024-2029)
5 Gene Therapy for Ovarian Cancer Breakdown Data by Application
5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy for Ovarian Cancer Market Size (2018-2029)
6.2 North America Gene Therapy for Ovarian Cancer Market Size by Type
6.2.1 North America Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023)
6.2.2 North America Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029)
6.2.3 North America Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
6.3 North America Gene Therapy for Ovarian Cancer Market Size by Application
6.3.1 North America Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023)
6.3.2 North America Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029)
6.3.3 North America Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
6.4 North America Gene Therapy for Ovarian Cancer Market Size by Country
6.4.1 North America Gene Therapy for Ovarian Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)
6.4.3 North America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2018-2029)
7.2 Europe Gene Therapy for Ovarian Cancer Market Size by Type
7.2.1 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023)
7.2.2 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029)
7.2.3 Europe Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Application
7.3.1 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023)
7.3.2 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029)
7.3.3 Europe Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Country
7.4.1 Europe Gene Therapy for Ovarian Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)
7.4.3 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy for Ovarian Cancer Market Size (2018-2029)
8.2 China Gene Therapy for Ovarian Cancer Market Size by Type
8.2.1 China Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023)
8.2.2 China Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029)
8.2.3 China Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
8.3 China Gene Therapy for Ovarian Cancer Market Size by Application
8.3.1 China Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023)
8.3.2 China Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029)
8.3.3 China Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene Therapy for Ovarian Cancer Market Size (2018-2029)
9.2 Asia Gene Therapy for Ovarian Cancer Market Size by Type
9.2.1 Asia Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023)
9.2.2 Asia Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029)
9.2.3 Asia Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
9.3 Asia Gene Therapy for Ovarian Cancer Market Size by Application
9.3.1 Asia Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023)
9.3.2 Asia Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029)
9.3.3 Asia Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
9.4 Asia Gene Therapy for Ovarian Cancer Market Size by Region
9.4.1 Asia Gene Therapy for Ovarian Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023)
9.4.3 Asia Gene Therapy for Ovarian Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Details
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction
11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)
11.1.5 Takara Bio Recent Developments
11.2 VBL Therapeutics
11.2.1 VBL Therapeutics Company Details
11.2.2 VBL Therapeutics Business Overview
11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction
11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)
11.2.5 VBL Therapeutics Recent Developments
11.3 CELSION
11.3.1 CELSION Company Details
11.3.2 CELSION Business Overview
11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction
11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)
11.3.5 CELSION Recent Developments
11.4 Targovax
11.4.1 Targovax Company Details
11.4.2 Targovax Business Overview
11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction
11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)
11.4.5 Targovax Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Intravenous
Table 3. Key Players of Intratumoral
Table 4. Key Players of Intraperitoneal
Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Region (2018-2023)
Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Region (2024-2029)
Table 11. Gene Therapy for Ovarian Cancer Market Trends
Table 12. Gene Therapy for Ovarian Cancer Market Drivers
Table 13. Gene Therapy for Ovarian Cancer Market Challenges
Table 14. Gene Therapy for Ovarian Cancer Market Restraints
Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gene Therapy for Ovarian Cancer Revenue Share by Players (2018-2023)
Table 17. Global Top Gene Therapy for Ovarian Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2022)
Table 18. Global Gene Therapy for Ovarian Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Gene Therapy for Ovarian Cancer, Headquarters and Area Served
Table 21. Global Key Players of Gene Therapy for Ovarian Cancer, Product and Application
Table 22. Global Key Players of Gene Therapy for Ovarian Cancer, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2018-2023)
Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2024-2029)
Table 28. Global Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gene Therapy for Ovarian Cancer Revenue Share by Application (2018-2023)
Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Gene Therapy for Ovarian Cancer Revenue Share by Application (2024-2029)
Table 32. North America Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Gene Therapy for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Gene Therapy for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Gene Therapy for Ovarian Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Gene Therapy for Ovarian Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 64. Takara Bio Company Details
Table 65. Takara Bio Business Overview
Table 66. Takara Bio Gene Therapy for Ovarian Cancer Product
Table 67. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)
Table 68. Takara Bio Recent Developments
Table 69. VBL Therapeutics Company Details
Table 70. VBL Therapeutics Business Overview
Table 71. VBL Therapeutics Gene Therapy for Ovarian Cancer Product
Table 72. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)
Table 73. VBL Therapeutics Recent Developments
Table 74. CELSION Company Details
Table 75. CELSION Business Overview
Table 76. CELSION Gene Therapy for Ovarian Cancer Product
Table 77. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)
Table 78. CELSION Recent Developments
Table 79. Targovax Company Details
Table 80. Targovax Business Overview
Table 81. Targovax Gene Therapy for Ovarian Cancer Product
Table 82. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)
Table 83. Targovax Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2022 VS 2029
Figure 3. Intravenous Features
Figure 4. Intratumoral Features
Figure 5. Intraperitoneal Features
Figure 6. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2022 VS 2029
Figure 8. Ovarian Cancer (Unspecified) Case Studies
Figure 9. Recurrent Ovarian Epithelial Cancer Case Studies
Figure 10. Platinum-Resistant Ovarian Cancer Case Studies
Figure 11. Gene Therapy for Ovarian Cancer Report Years Considered
Figure 12. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Gene Therapy for Ovarian Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gene Therapy for Ovarian Cancer Market Share by Region: 2022 VS 2029
Figure 15. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2022
Figure 16. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2022
Figure 18. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
Figure 20. North America Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
Figure 21. North America Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)
Figure 22. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Gene Therapy for Ovarian Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
Figure 26. Europe Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
Figure 27. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)
Figure 28. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Gene Therapy for Ovarian Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
Figure 36. China Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
Figure 37. Asia Gene Therapy for Ovarian Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
Figure 39. Asia Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
Figure 40. Asia Gene Therapy for Ovarian Cancer Market Share by Region (2018-2029)
Figure 41. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)
Figure 51. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)
Figure 58. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)
Figure 59. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)
Figure 60. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed